In another pathological context, administration of BRD4 inhibitors, 2 or 4 h post-ischemic stroke, protected against brain damage by reducing inflammation, oxidative stress and the activation of NLRP3 inflammasome 39, 40. This evidence concerns the gene NLRP3 and ischemic stroke.